CD9 and breast carcinoma: We characterizethe EV secretion of two breast cancer cell lines: triple-negativeMDA-MB-231 cells and HER2-positive SkBr3 cells secrete EVs that carrydistinguishable levels of tetraspanins (CD9, CD63, and CD81) and HSPs(−90 and −70).